Prolonged Anaphylaxis to Pfizer Coronavirus Disease 2019 Vaccine: A Case Report and Mechanism of Action

Keyphrases

• Mechanism of Action 100%
• Anaphylaxis 100%
• Pfizer 100%
• Coronavirus Disease 2019 Vaccine 100%
• BNT162b2 75%
• Etiology 25%
• Clinical Trials 25%
• Tongue 25%
• Edema 25%
• Epinephrine 25%
• Critical Care Management 25%
• Respiratory Distress 25%
• Messenger RNA (mRNA) 25%
• Polyethylene Glycol 25%
• Safety Profile 25%
• Allergy 25%
• Young Female 25%
• Literature Search 25%
• General Public 25%
• Disease Prevention 25%
• Allergic Reaction 25%
• COVID-19 Pandemic 25%
• Centers for Disease Control 25%
• Anaphylactic Reaction 25%
• Premedication 25%
• First Dose 25%
• Diphenhydramine 25%
• Possible Causes 25%
• Second Dose 25%
• Extended Period 25%
• Hive 25%
• Emergency Use Authorization 25%
• Pfizer-BioNTech BNT162b2 25%
• RNA-based Vaccines 25%
• Vaccine Prototype 25%
• Nasoendoscopy 25%
• Protracted Anaphylaxis 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Coronavirinae 100%
• Anaphylaxis 100%
• Diseases 100%
• Edema 16%
• Epinephrine 16%
• Clinical Trial 16%
• Respiratory Distress 16%
• Allergic Reaction 16%
• Diphenhydramine 16%
• Macrogol 16%
• Urticaria 16%
• Messenger RNA 16%
• Excipient 16%

Medicine and Dentistry

• COVID-19 100%
• Anaphylaxis 100%
• Clinical Trial 16%
• Tongue 16%
• Intensive Care 16%
• Respiratory Distress 16%
• Infusion 16%
• Urticaria 16%
• Epinephrine 16%
• Edema 16%
• Allergic Response 16%
• Premedication 16%
• Diphenhydramine 16%
• Macrogol 16%
• Excipient 16%
• Messenger RNA 16%
• Diseases 16%